Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava filters -- devices used to keep blood clots from ...

(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA ...

Plaintiffs in a Multi District Litigation (“MDL”) filed complaints against Cook Medical Inc. (“Cook”) and alleges that Cook knowingly presented false information regarding the safety profile of its ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Inferior Vena Cava Filters (IVCF) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...

Unsealed court documents from lawsuits over inferior vena cava (IVC) filters expose a big gap between what manufacturers and regulators know about the safety of a medical device and how much of that ...

FAIRFAX, Va.--The first large-scale, multispecialty prospective clinical research trial to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United ...

FAIRFAX, Va.—Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep ...

Debates continue over the merits of inferior vena cava (IVC) filters for patients with venous thromboembolism (VTE), with two viewpoints on the topic—one yea and the other nay—published online earlier ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the Global Inferior Vena Cava (IVC) Filter Market 2025-2035," provides a ...

C.R. Bard ($BCR) revealed in an SEC filing that its facilities in Glens Falls, NY, and Tempe, AZ, are under an FDA warning letter for misfiling customer complaints ...